Effects of carvedilol alone and in the presence of cyclosporine A on the DNA synthesis of cultured vascular smooth muscle cells

Surgery Today

Volumn 32, Issue 3, 2002, Pages 230-235

  Kim, Yu Seun ^a,b   Kim, Myoung Soo ^b,c   Ha, Hunjoo ^b   Park, Jehyun ^b   Kim, Hae Jin ^a   Park, Kiil ^a,b  

^a Department of Surgery and ^*  (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University Wonju   (South Korea)

Author keywords

Carvedilol; Cyclosporine; Proliferation; Smooth muscle cell

Indexed keywords

ANGIOTENSIN; CARVEDILOL; CYCLOSPORIN A; ENDOTHELIN 1; PLATELET DERIVED GROWTH FACTOR BB; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTERIOSCLEROSIS; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DETERMINATION; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; HYPERTENSION; IC 50; INHIBITION KINETICS; ISOTOPE LABELING; NONHUMAN; RAT; RECIPIENT; SMOOTH MUSCLE FIBER; THORACIC AORTA; TRANSPLANTATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CARBAZOLES; CELLS, CULTURED; CYCLOSPORINE; DNA; IMMUNOSUPPRESSIVE AGENTS; MUSCLE, SMOOTH, VASCULAR; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036207388     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950200026     Document Type: Article

References (30)

1. The registry of the international society for heart and lung transplantation: Thirteenth official report (1996)
2. Both alloantigen-dependent and -independent factors influence chronic allograft rejection
3. Vascular smooth muscle cells and neointimal hyperplasia in chronic transplant rejection
4. Chronic remodeling pathology in grafts
5. Vascular effects of cyclosporine A in vivo and in vitro
6. Cyclosporine A inhibits induction of DNA synthesis by PDGF and other peptide mitogens in cultured rat aortic smooth muscle cells and dermal fibroblasts
7. Direct and endothelial cell-mediated effect of cyclosporine A on the proliferation of rat smooth muscle cells in vitro
8. Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis
9. Effect of cyclosporine A on rat smooth muscle cell proliferation
10. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle cell and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor
11. Carvedilol inhibits vascular smooth muscle cell proliferation
12. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury
13. Inhibition of human vascular smooth muscle cell proliferation by the novel multi-action antihypertensive agent carvedilol
14. Association of chronic graft failure with recipient blood pressure. Collaborative transplant study
15. Importance of PDGF receptor expression in accelerated atherosclerosis - Chronic rejection
16. Role of platelet-derived growth factor in allograft vasculopathy
17. Endothelin in coronary endothelial dysfunction early after human heart transplantation
18. Role of endothelin in cyclosporine-induced glomerular dysfunction
19. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
20. Mitogenic effect of angiogensin II on rat carotid arteries and type II or III mesenteric microvessels but not type I mesenteric microvessels is mediated by endogenous basicfibroblast growth factor
21. Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: In vitro study
22. Carvedilol
23. Systemic and renal hemodynamic response to carvedilol and metoprolol in hypertensive renal transplant patients
24. Treatment with carvedilol is associated with a significant reduction in microalbuminuria: A multicentre randomized study
25. Carvedilol treatment of kidney graft recipients with chronic rejection
26. Carvedilol, a multi-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells
27. Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury
28. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection
29. Antioxidant action of the antihypertensive drugs, carvedilol, against lipid peroxidation
30. Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells